Literature DB >> 21056450

HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.

Sharof M Tugizov1, Rossana Herrera, Piri Veluppillai, Deborah Greenspan, Vanessa Soros, Warner C Greene, Jay A Levy, Joel M Palefsky.   

Abstract

Oral transmission of human immunodeficiency virus (HIV) in adult populations is rare. However, HIV spread across fetal/neonatal oropharyngeal epithelia could be important in mother-to-child transmission. Analysis of HIV transmission across polarized adult and fetal oral epithelial cells revealed that HIV transmigrates through both adult and fetal cells. However, only virions that passed through the fetal cells - and not those that passed through the adult cells - remained infectious. Analysis of expression of anti-HIV innate proteins beta-defensins 2 and 3, and secretory leukocyte protease inhibitor in adult, fetal, and infant oral epithelia showed that their expression is predominantly in the adult oral epithelium. Retention of HIV infectivity after transmigration correlated inversely with the expression of these innate proteins. Inactivation of innate proteins in adult oral keratinocytes restored HIV infectivity. These data suggest that high-level innate protein expression may contribute to the resistance of the adult oral epithelium to HIV transmission.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056450      PMCID: PMC3034249          DOI: 10.1016/j.virol.2010.10.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  79 in total

1.  Oral SIV, SHIV, and HIV type 1 infection.

Authors:  R M Ruprecht; T W Baba; V Liska; S Ayehunie; J Andersen; D C Montefiori; A Trichel; M Murphey-Corb; L Martin; T A Rizvi; B J Bernacky; S J Buchl; M Keeling
Journal:  AIDS Res Hum Retroviruses       Date:  1998-04       Impact factor: 2.205

Review 2.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

Review 3.  Breast-feeding, mastitis, and HIV transmission: nutritional implications.

Authors:  R D Semba; M C Neville
Journal:  Nutr Rev       Date:  1999-05       Impact factor: 7.110

4.  Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates.

Authors:  Y Ganor; Z Zhou; D Tudor; A Schmitt; M-C Vacher-Lavenu; L Gibault; N Thiounn; J Tomasini; J-P Wolf; M Bomsel
Journal:  Mucosal Immunol       Date:  2010-06-23       Impact factor: 7.313

5.  Per-contact risk of human immunodeficiency virus transmission between male sexual partners.

Authors:  E Vittinghoff; J Douglas; F Judson; D McKirnan; K MacQueen; S P Buchbinder
Journal:  Am J Epidemiol       Date:  1999-08-01       Impact factor: 4.897

6.  Evaluating the risk of HIV transmission through unprotected orogenital sex.

Authors:  Jorge del Romero; Beatriz Marincovich; Jesús Castilla; Soledad García; Julián Campo; Victoria Hernando; Carmen Rodríguez
Journal:  AIDS       Date:  2002-06-14       Impact factor: 4.177

7.  Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.

Authors:  N K Jana; L R Gray; D C Shugars
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on human colonic epithelial cells.

Authors:  N Yahi; S L Spitalnik; K A Stefano; P De Micco; F Gonzalez-Scarano; J Fantini
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

9.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

Authors:  T B McNeely; M Dealy; D J Dripps; J M Orenstein; S P Eisenberg; S M Wahl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

Authors:  J W Burns; M Siadat-Pajouh; A A Krishnaney; H B Greenberg
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

View more
  33 in total

1.  Epstein-Barr virus transcytosis through polarized oral epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Joel M Palefsky
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 2.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

Review 3.  Mucosal transmission of human immunodeficiency virus.

Authors:  Denis M Tebit; Nicaise Ndembi; Aaron Weinberg; Miguel E Quiñones-Mateu
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

4.  HIV pre-exposure prophylaxis for women and infants prevents vaginal and oral HIV transmission in a preclinical model of HIV infection.

Authors:  Martina Kovarova; Uma Shanmugasundaram; Caroline E Baker; Rae Ann Spagnuolo; Chandrav De; Christopher C Nixon; Angela Wahl; J Victor Garcia
Journal:  J Antimicrob Chemother       Date:  2016-08-01       Impact factor: 5.790

Review 5.  Defensins at the Mucosal Surface: Latest Insights into Defensin-Virus Interactions.

Authors:  Sarah S Wilson; Mayim E Wiens; Mayumi K Holly; Jason G Smith
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

Review 6.  Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease.

Authors:  Sharof Tugizov
Journal:  Tissue Barriers       Date:  2016-03-03

7.  Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia.

Authors:  Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

8.  HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus.

Authors:  Sharof M Tugizov; Rossana Herrera; Peter Chin-Hong; Piri Veluppillai; Deborah Greenspan; J Michael Berry; Christopher D Pilcher; Caroline H Shiboski; Naomi Jay; Mary Rubin; Aung Chein; Joel M Palefsky
Journal:  Virology       Date:  2013-09-17       Impact factor: 3.616

Review 9.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients.

Authors:  Alcina F Nicol; Laurie L Brunette; Gerard J Nuovo; Beatriz Grinsztejn; Ruth K Friedman; Valdiléa G Veloso; Cynthia B Cunha; José R Coutinho; Cecilia Vianna-Andrade; Nathalia S Oliveira; Andrew W Woodham; Diane M DA Silva; W Martin Kast
Journal:  J Acquir Immune Defic Syndr       Date:  2016-09-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.